Skip to content

NDMM ~ Tweetorial #1: Efficacy of Quad Therapies
***Post-Survey & Application for Credit***

In order to receive credit for this activity, you must read the front matter, view the activity, achieve a passing of 100% on this post-survey, as well as complete the linked evaluation and application for credit form. Certificates of credit will be emailed to participants who have successfully met these requirements.

There is no fee to participate in this activity.
1.What are your specialty & credentials?(Required.)
2.What is your community of practice?
3.CEPHEUS compared induction/consolidation w VRd ± daratumumab (D) followed by maintenance in transplant-ineligible (TIE) NDMM.

DVRd arm demonstrated which of the following outcomes?(Required.)
4.Unfortunately, pts w high-risk (HR) NDMM have 👎prognosis & shorter survival rates vs standard-risk.

Based on results of GMMG-CONCEPT presented at ASCO2025, which treatment strategy should be used for pts w/HRNDMM?(Required.)
EVALUATION FORM
5.Upon completion of this activity, I am able to:
Strongly agree
Agree
Disagree
Strongly disagree
Appraise efficacy data from pivotal clinical trials assessing current and emerging quadruplet therapies
Interpret the role of MRD in guiding decision-making for patients with NDMM
6.Please indicate the extent of your agreement with the following statements:
Strongly agree
Agree
Disagree
Strongly disagree
The faculty for this activity were effective
The educational resources provided to me at the educational activity are useful to my practice
7.Overall, was this activity fair, balanced and free from commercial bias?
8.If no, please explain:
9.Of the patients with multiple myeloma you will see in the next month, about how many will benefit from the information you learned today?
10.Based on what I learned today, I will improve my practice by incorporating the following (check all that apply):
11.Based on your experience, which of the following are the primary barriers to implementing changes in practice (check all that apply):
12.For purposes of certification, you must complete the following information.
*Please note that we will not forward or sell your contact information.*(Required.)
13.I certify that I have participated in the continuing education activity entitled, "Four is More: Selecting and Optimizing Quadruplet Therapy in Newly Diagnosed Multiple Myeloma | How I Practice" and claim 0.5 AMA PRA Category 1 CreditTM.(Required.)
Thank you for participating in our activity and completing the necessary paperwork. Your certificate will be emailed to you using the email address provided above. Please allow 4 weeks to receive your certificate.

For information about the certification of this program, please contact Global at 303-395-1782 or cme@globaleducationgroup.com.
Privacy & Cookie Notice